Suelen Baggio
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Suelen Baggio has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Marta Barbara Wisniewska
Centre of New Technologies, University of Warsaw, Poland
4 shared publications - Agnieszka Chacinska
IMol Polish Academy of Sciences, Warsaw, Poland
2 shared publications - Andrzej Nagalski
Centre of New Technologies, University of Warsaw, Poland
2 shared publications Anna Goncerzewicz
BRAINCITY - Centre of Excellence for Neural Plasticity and Brain Disorders, Nencki Institute of Experimental Biology, Warsaw, Poland
2 shared publications- Ben Hur Marins Mussulini
Programa de Pós-graduação em Bioquímica, Departamento de Bioquímica, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul, Rua Ramiro Barcelos 2600-Anexo, 90035-003 Porto Alegre, RS, Brazil
2 shared publications - Ewelina Knapska
Laboratory of Emotions Neurobiology, BRAINCITY - Centre of Excellence for Neural Plasticity and Brain Disorders, Nencki Institute of Experimental Biology, Polish Academy of Sciences, Warsaw, Poland
2 shared publications
Latest Publications
- Open Access
β-catenin–independent regulation by TCF7L2 underlies isoform redundancy during embryonic thalamic development
Alternative isoforms of transcription factors are common during brain development, but their functional significance remains poorly defined. One example is TCF7L2, a transcription factor critical for developing the thalamus and autism spectrum-associated gene. It exists in two isoforms from different promoters: the long isoform (L-TCF7L2) with the β-catenin-binding domain, and the shorter isoform (S-TCF7L2), lacking this domain and classically considered a dominant-negative regulator of the L isoform. Here, we investigated the role of TCF7L2 isoforms in thalamic development using total and isoform-specific knockout strategies. Analysis of axonal phenotypes, regional markers, and RNA-seq uncovered that the isoforms are functionally redundant during development. Immunohistochemistry and ChIP-seq showed that in the embryonic thalamus — unlike in the postnatal thalamus — TCF7L2 regulates gene expression independently of β-catenin. These findings reveal a switch from β-catenin–independent and isoform-redundant to classical β-catenin–dependent TCF7L2 activity, occurring between the embryonic and postnatal stages. This suggests that alternative promoter usage may, in some contexts, ensure robust availability of the regulatory protein during brain development.
Open Accessβ-catenin–independent regulation by TCF7L2 underlies isoform redundancy during embryonic thalamic development
Alternative isoforms of transcription factors are common during brain development, but their functional significance remains poorly defined. One example is TCF7L2, a transcription factor critical for developing the thalamus and autism spectrum-associated gene. It exists in two isoforms from different promoters: the long isoform (L-TCF7L2) with the β-catenin-binding domain, and the shorter isoform (S-TCF7L2), lacking this domain and classically considered a dominant-negative regulator of the L isoform. Here, we investigated the role of TCF7L2 isoforms in thalamic development using total and isoform-specific knockout strategies. Analysis of axonal phenotypes, regional markers, and RNA-seq uncovered that the isoforms are functionally redundant during development. Immunohistochemistry and ChIP-seq showed that in the embryonic thalamus — unlike in the postnatal thalamus — TCF7L2 regulates gene expression independently of β-catenin. These findings reveal a switch from β-catenin–independent and isoform-redundant to classical β-catenin–dependent TCF7L2 activity, occurring between the embryonic and postnatal stages. This suggests that alternative promoter usage may, in some contexts, ensure robust availability of the regulatory protein during brain development.
- Open Access
The Role of TCF7L2 in Regulating Energy Metabolism in Thalamocortical Circuitry and its Broader Impact on Social Behavior
Psychiatric and metabolic disorders often co-occur. While shared genetic factors and cellular dysfunctions are implicated, the underlying molecular mechanisms remain poorly understood. TCF7L2, a risk gene for type 2 diabetes and autism spectrum disorder, is highly expressed in the thalamus—a brain region extensively interconnected with the cortex, playing a key role in sensory processing, motor control, and behavioral regulation. Given its known role as a transcription factor regulating systemic energy metabolism, we explored its potential contribution to brain metabolism and behavior. To this end, we used a conditional knockout model with postnatal TCF7L2 loss in the thalamus and partial deficiency in the pancreas. Tcf7l2 knockout mice exhibited social deficits and reduced motor habituation. In parallel, they also developed systemic glucose intolerance, modelling the psychiatric-metabolic comorbidity. Thalamic depletion of TCF7L2 resulted in elevated inhibitory phosphorylation of the pyruvate dehydrogenase —an enzymatic gatekeeper for pyruvate utilization in energy production—in the thalamus and cortex. This was accompanied by altered thalamic and cortical metabolism, characterized by reduced efficiency of pyruvate oxidation alongside enhanced oxidation of fatty acids and ketone bodies. Notably, a ketogenic diet alleviated metabolic dysregulation in the brain and normalized some social behaviors in knockout mice. These findings suggest that impaired energy metabolism in the thalamocortical circuitry may represent one of the pathogenic mechanisms underlying neuropsychiatric symptoms.
Open AccessThe Role of TCF7L2 in Regulating Energy Metabolism in Thalamocortical Circuitry and its Broader Impact on Social Behavior
Psychiatric and metabolic disorders often co-occur. While shared genetic factors and cellular dysfunctions are implicated, the underlying molecular mechanisms remain poorly understood. TCF7L2, a risk gene for type 2 diabetes and autism spectrum disorder, is highly expressed in the thalamus—a brain region extensively interconnected with the cortex, playing a key role in sensory processing, motor control, and behavioral regulation. Given its known role as a transcription factor regulating systemic energy metabolism, we explored its potential contribution to brain metabolism and behavior. To this end, we used a conditional knockout model with postnatal TCF7L2 loss in the thalamus and partial deficiency in the pancreas. Tcf7l2 knockout mice exhibited social deficits and reduced motor habituation. In parallel, they also developed systemic glucose intolerance, modelling the psychiatric-metabolic comorbidity. Thalamic depletion of TCF7L2 resulted in elevated inhibitory phosphorylation of the pyruvate dehydrogenase —an enzymatic gatekeeper for pyruvate utilization in energy production—in the thalamus and cortex. This was accompanied by altered thalamic and cortical metabolism, characterized by reduced efficiency of pyruvate oxidation alongside enhanced oxidation of fatty acids and ketone bodies. Notably, a ketogenic diet alleviated metabolic dysregulation in the brain and normalized some social behaviors in knockout mice. These findings suggest that impaired energy metabolism in the thalamocortical circuitry may represent one of the pathogenic mechanisms underlying neuropsychiatric symptoms.
- Open Access
- 5 November 2023
- Published by Elsevier in IBRO Neuroscience Reports
- Vol. 15, S102
THE ROLE OF TCF7L2 TRANSCRIPTION FACTOR IN THE FUCTION OF THALAMO-CORTICAL CIRCUITS AND IN PATHOGENESIS OF AUTISM SPECTRUM DISORDER
- 5 November 2023
- Published by Elsevier in IBRO Neuroscience Reports
- Vol. 15, S102
Open AccessTHE ROLE OF TCF7L2 TRANSCRIPTION FACTOR IN THE FUCTION OF THALAMO-CORTICAL CIRCUITS AND IN PATHOGENESIS OF AUTISM SPECTRUM DISORDER
- Open Access
- 5 November 2023
- Published by Elsevier in IBRO Neuroscience Reports
- Vol. 15, S74-S75
TCF7L2 DEFICIENCY IN THE THALAMUS LEADS TO ALTERATIONS IN BEHAVIORAL PROFILE AND BRAIN ENERGY METABOLISM
- 5 November 2023
- Published by Elsevier in IBRO Neuroscience Reports
- Vol. 15, S74-S75
Open AccessTCF7L2 DEFICIENCY IN THE THALAMUS LEADS TO ALTERATIONS IN BEHAVIORAL PROFILE AND BRAIN ENERGY METABOLISM
- 1 May 2020
- Published by Elsevier in NeuroToxicology
- Vol. 78, 152-160
Fetal alcohol spectrum disorders model alters the functionality of glutamatergic neurotransmission in adult zebrafish
- 1 May 2020
- Published by Elsevier in NeuroToxicology
- Vol. 78, 152-160
Fetal alcohol spectrum disorders model alters the functionality of glutamatergic neurotransmission in adult zebrafish